XML 117 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (135,376) $ (41,811)
Adjustments to reconcile net loss to net cash flow from operating activities    
Stock-based compensation 19,694 19,390
Depreciation and amortization 4,263 2,689
(Accretion) amortization of note premiums/discounts (835) 690
Realized gain on investments (80) 0
Non-cash interest expense on liability related to the sale of future royalties 5,367 2,849
Changes in operating assets and liabilities:    
Accounts receivable 0 (38,157)
Prepaid expenses and other current assets (1,748) 10,529
Accounts payable (12,463) (2,072)
Accrued expenses 408 (7,203)
Deferred revenue (866) (22,979)
Operating lease, net 3,796 559
Net cash used in operating activities (117,840) (75,516)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (68,656) (38,911)
Purchases of investments 0 (111,199)
Proceeds from sales and maturities of investments 133,495 69,416
Net cash provided by (used in) investing activities 64,839 (80,694)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the exercises of stock options 267 576
Proceeds from the sale of future royalties 0 250,000
Net cash provided by financing activities 267 250,576
Net (decrease) increase in cash, cash equivalents and restricted cash (52,734) 94,366
Effect of exchange rate on cash, cash equivalents and restricted cash 58 (122)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH:    
BEGINNING OF PERIOD 110,891 108,005
END OF PERIOD 58,215 202,249
Supplementary disclosure of cash flows:    
Interest paid 0 0
Income taxes (paid) refunded (999) 0
Supplemental disclosure of noncash investing activities:    
Capital expenditures included in accrued expenses $ 11,290 $ 14,044